Does MEPOLIZUMAB Cause Transient ischaemic attack? 151 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 151 reports of Transient ischaemic attack have been filed in association with MEPOLIZUMAB (Nucala). This represents 0.4% of all adverse event reports for MEPOLIZUMAB.
151
Reports of Transient ischaemic attack with MEPOLIZUMAB
0.4%
of all MEPOLIZUMAB reports
16
Deaths
86
Hospitalizations
How Dangerous Is Transient ischaemic attack From MEPOLIZUMAB?
Of the 151 reports, 16 (10.6%) resulted in death, 86 (57.0%) required hospitalization, and 14 (9.3%) were considered life-threatening.
Is Transient ischaemic attack Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEPOLIZUMAB. However, 151 reports have been filed with the FAERS database.
What Other Side Effects Does MEPOLIZUMAB Cause?
Asthma (11,033)
Dyspnoea (9,192)
Wheezing (6,093)
Product dose omission issue (5,873)
Cough (4,577)
Pneumonia (4,107)
Therapeutic product effect incomplete (4,106)
Drug ineffective (3,880)
Loss of personal independence in daily activities (3,566)
Fatigue (2,656)
What Other Drugs Cause Transient ischaemic attack?
APIXABAN (1,157)
RIVAROXABAN (820)
LENALIDOMIDE (655)
ADALIMUMAB (604)
ASPIRIN (587)
ROSIGLITAZONE (585)
NAPROXEN (521)
LEVOTHYROXINE (517)
DABIGATRAN ETEXILATE (471)
CLOPIDOGREL BISULFATE (454)
Which MEPOLIZUMAB Alternatives Have Lower Transient ischaemic attack Risk?
MEPOLIZUMAB vs MEPROBAMATE
MEPOLIZUMAB vs MERCAPTOPURINE
MEPOLIZUMAB vs MEROPENEM
MEPOLIZUMAB vs MEROPENEM ANHYDROUS
MEPOLIZUMAB vs MESALAMINE